Inhibiting the activation of the MAPK/MMP, Rho/Rho-associated protein kinase and PI3K/Akt/mTOR signaling pathways correlates to ginkgolic acid C17:1-induced tumor suppression. Here, AKT1 is linked to neoplasm.